hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas

Cancer Genetics and Cytogenetics

Volumn 116, Issue 2, 2000, Pages 142-147

  Bello, M J ^a,b   De Campos, J M ^c   Vaquero, J ^d   Ruiz Barnes P ^e   Kusak, M E ^c   Sarasa, J L ^e   Rey, J A ^b  

^a Pediatric Neurology Unit Hospital   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE;

ARTICLE; CHROMOSOME 1P; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA HELICASES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0033992082     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00122-3     Document Type: Article

References (27)

1. Rasio D., Murakumo Y., Robbins D., Roth T., Silver A., Negrini M., Schmidt C., Burczak J., Fishel R., Croce Carlo M. Characterization of the human homologue of RAD54. a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors Cancer Res. 57:1997;2378-2383.
2. Kanaar R., Troelstra C., Swagemakers S.M.A., Essers J., Smit B., Franssen J.-H., Pastink A., Bezzubova O.Y., Buerstedde J.-M., Clever B., Heyer W.-D., Hoeijmakers J.H.J. Human and mouse homologs of the Saccharomyces cerevisiae RAD54 DNA repair gene. evidence for functional conservation Curr Biol. 6:1996;828-838.
3. Sung P., Bailly V., Weber C., Thompson L.H., Prakash L., Prakash S. Human xeroderma pigmentosum group D genes encode a DNA helicase. Nature. 365:1993;852-855.
4. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell. 83:1995;655-666.
5. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J., Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science. 272:1996;258-262.
6. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell. 82:1995;321-330.
7. Reitmair A.H., Scmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.-W., Wakeman A., Liu B., Thomason A., Griesser H., Gallinger S., Balhausen W.G., Fishel R., Mak T.W. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet. 11:1995;64-70.
8. Retmair A.H., Redston M., Cai J.C., Chuang T.Y.C., Bjerknes M., Cheng H., Hay K., Gallinger S., Bapat B., Mak T.W. Spontaneous intestinal carcinomas and skin neoplasms in MSH2-deficient mice. Cancer Res. 56:1996;3842-3849.
9. Bello M.J., Vaquero J., de Campos J.M., Kusak M.E., Sarasa J.L., Saez J., Pestaña A., Rey J.A. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer. 57:1994;172-175.
10. Reifemberger J., Reifemberger G., Liu L., James C.D., Wechsler W., Collins V.P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol. 145:1994;1175-1190.
11. Bello M.J., Leone P.E., Vaquero J., de Campos J.M., Kusak M.E., Sarasa J.L., Pestaña A., Rey J.A. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer. 64:1995;207-210.
12. Kraus J.A., Koopmann J., Kaskel P., Maintz D., Brandner S., Schramm J., Louis D.N., Wiestler O.D., von Deimling A. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol. 54:1995;91-95.
13. Maintz D., Fiedler K., Koopmann J., Rollbrocker B., Nechev S., Lenartz D., Stangl A.P., Louis D.N., Schramm J., Wiestler O.D., von Deimling A. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neurol Exp Neurol. 56:1997;1098-1104.
14. Rosso S.M., van Dekken H., Krishnadath K.K., Alers J.C., Kros J.M. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol. 56:1997;1125-1131.
15. Zhu J.J., Santarius T., Wu X., Tsong J., Guha A., Wu J.K., Hudson T.J., Black P.M. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosom Cancer. 21:1998;207-216.
16. Rey J.A., Bello M.J., Jimenez Lara A., Vaquero J., Kusak M.E., de Campos J.M., Sarasa J.L., Pestaña A. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer. 51:1992;703-706.
17. Leone P.E., Bello M.J., de Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., Rey J.A. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene. 18:1999;2231-2239.
18. Bender B., Wiestler O.D., von Deimling A. A device for processing large acrylamide gels. Biotechniques. 16:1994;204-206.
19. Mendiola M., Bello M.J., Alonso J., Leone P.E., Vaquero J., Sarasa J.L., Kusak M.E., de Campos J.M., Pestaña A., Rey J.A. Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32. Mol Carcinog. 24:1999;300-304.
20. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestaña A., Rey J.A. Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet. 73:1994;122-129.
21. Ransom D.T., Ritland S.R., Moertel C.A., Dahl R.J., O'Fallon J.R., Scheitauer B.W., Kimmel D.W., Kelly P.J., Olopade O.I., Diaz M.O., Jenkins R.B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytoma. Genes Chromosom Cancer. 5:1994;357-374.
22. von Deimling A., Louis D.N., von Ammon K., Petersen I., Wiestler O.D., Seizinger B.R. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res. 52:1992;4277-4279.
23. Rubio M.P., Correa K.M., Ueki K., Mohrenweiser H.W., Gusella J.F., von Deimling A., Louis D.N. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Res. 54:1994;4760-4763.
24. Bello M.J., Leone P.E., Nebreda P., Kusak M.E., de Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., Rey J.A. Molecular abnormalities of chromosome 19 in malignant gliomas. preferential involvement of the 19q13.2~q13.4 region Int J Oncol. 6:1995;655-658.
25. Ritland S.R., Ganju V., Jenkins R.B. Region-specific loss of heterozygosity on chromosome 19 is related to morphologic type of human glioma. Genes Chromosom Cancer. 12:1995;277-282.
26. Chou D., Miyashita T., Mohrenweiser H.W., Ueki K., Kastury K., Druck T., von Deimling A., Huebner K., Reed J.C., Louis D.N. The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genet Cytogenet. 88:1996;136-140.
27. Mai M., Huang H., Reed C., Qian C., Smith J.S., Alderete B., Jenkins R., Smith D.I., Liu W. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics. 51:1998;359-363.